Hostname: page-component-54dcc4c588-tfzs5 Total loading time: 0 Render date: 2025-10-05T12:12:36.790Z Has data issue: false hasContentIssue false
  • English
  • Français

Trials of intranasally administered rubella vaccine

Published online by Cambridge University Press:  15 May 2009

Irene B. Hillary
Irene B. Hillary
Affiliation:
Department of Medical Microbiology, University College, Dublin
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

No evidence of vaccine virus transmission was found in two studies where Wistar RA 27/3 rubella vaccine was administered intranasally. Vaccine was immunogenic in all of 23 vaccinated children in one study, while in the other only 5 of the 11 vaccinees developed antibody. The reduced seroconversion rate in the latter study appears to have been caused by one or a combination of factors, including the vaccination technique, the presence of infective nasal conditions in vaccinees and the titre of vaccine used.

Information

Type
Research Article
Information
Journal of Hygiene , Volume 69 , Issue 4 , December 1971 , pp. 547 - 552
Copyright
Copyright © Cambridge University Press 1971

References

REFERENCES

Chang, T., Desrosiers, S. & Weinstein, L. (1970). Clinical and serologic studies of an outbreak of rubella in a vaccinated population. New England Journal of Medicine 283, 246.CrossRefGoogle Scholar
Hillary, I. B. (1971). Rubella serological survey on Irish school children. Irish Journal of Medical Science 140, 295.CrossRefGoogle ScholarPubMed
Hillary, I. B., Meenan, P. N., Griffith, A. H., Draper, C. C. & Laurence, G. D. (1969). Rubella vaccine trial in children. British Medical Journal ii, 531.CrossRefGoogle Scholar
Horstmann, D. M., Leibhaber, H., Le Bouvier, G. L., Rosenberg, D. A. & Halstead, S. B. (1970). Rubella re-infection of vaccinated and naturally immune persons. New England Journal of Medicine 283, 771.CrossRefGoogle ScholarPubMed
Ingalls, T. H., Plotkin, S. A., Philbrook, F. R. & Thompson, R. F. (1970). Immunization of school children with Rubella (RA 27/3) vaccine. Lancet i, 99.CrossRefGoogle Scholar
Mann, J. J., Rossen, R. D., Lehrich, J. R. & Kasel, J. A. (1967). The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus haemagglutination. Journal of Immunology 98, 1136.CrossRefGoogle Scholar
Peetermans, J. & Huygelen, C. (1967). L'emploi d'hérmaties de pigeons dans le test d'inhibition de l'héraagglutination de la rubéole. Presse Médicale 75, 2177.Google Scholar
Plotkin, S. A., Bechtel, D. J. & Sedwick, W. D. (1968). A simple method for removal of rubella haemagglutination inhibitors from serum adaptable to finger tip blood. American Journal of Epidemiology 88, 301.CrossRefGoogle ScholarPubMed
Plotkin, S. A., Farquhar, J. D., Katz, M. & Buser, F. (1969). Attenuation of RA 27/3 rubella virus in W1–38 human diploid cells. American Journal of Diseases of Children 118, 178.Google Scholar
Smith, R. T. (1969). Gamma-A immunoglobulins and the concept of local immunity. Pediatrics, Springfield 43, 317.CrossRefGoogle ScholarPubMed
Stewart, G. L., Parkman, P. D., Hopps, H. E., Douglas, R. D., Hamilton, J. P. & Meyer, M. H. (1967). Rubella virus haemagglutination-inhibition test. New England Journal of Medicine 276, 554.CrossRefGoogle Scholar
Tyrrell, D. A. J (1969). Some recent trends in vaccination against respiratory viruses. British Medical Bulletin 25, 165.CrossRefGoogle ScholarPubMed